Fatty acid–binding proteins as emerging immunometabolic regulators and therapeutic targets in multiple sclerosis and neurodegeneration: Promise, mechanistic gaps, and translational hurdles
Fatty acid–binding proteins as emerging immunometabolic regulators and therapeutic targets in multiple sclerosis and neurodegeneration: Promise, mechanistic gaps, and translational hurdles. // ASPET Discovery. – URL: https://www.sciencedirect.com/science/article/pii/S3050567426000143?dgcid=rss_sd_all
Fatty acid–binding proteins as emerging immunometabolic regulators and therapeutic targets in multiple sclerosis and neurodegeneration: Promise, mechanistic gaps, and translational hurdles. ASPET Discovery. https://www.sciencedirect.com/science/article/pii/S3050567426000143?dgcid=rss_sd_all
“Fatty acid–binding proteins as emerging immunometabolic regulators and therapeutic targets in multiple sclerosis and neurodegeneration: Promise, mechanistic gaps, and translational hurdles.” ASPET Discovery.
@article{article29515,
title = {Fatty acid–binding proteins as emerging immunometabolic regulators and therapeutic targets in multiple sclerosis and neurodegeneration: Promise, mechanistic gaps, and translational hurdles},
journal = {ASPET Discovery},
url = {https://www.sciencedirect.com/science/article/pii/S3050567426000143?dgcid=rss_sd_all}
}